Patent ID: 6689869
Filing Date: 2004-02-10
Classification: A61K,A61P,C07K,Y10S

Abstract:
A labeled humanized antibody or fragment, wherein said antibody or fragment specifically binds to human CD18 antigen and wherein the complementarity determining regions (CDR1, CDR2 and CDR3) of the light chain variable region and the complementarity determining regions (CDR1, CDR2 and CDR3) of the heavy chain variable region have the following amino acid sequences:light chain: CDR1 (SEQ ID NO: 4) CDR2 (SEQ ID NO: 6) CDR3 (SEQ ID NO: 8) heavy chain: CDR1 (SEQ ID NO: 12) CDR2 (SEQ ID NO: 14) CDR3 (SEQ ID NO: 16), wherein said humanized antibody or fragment is labeled.